Kapillarmikroskopie

Sander O, Sunderkötter C, Kötter I et al (2010) Kapillarmikroskopie Durchführung und Nomenklatur. Z Rheumatol 69:253–262 http://www.rheumaakademie.de/fileadmin/media/20120507_RhA_Flyer_Kapillar_Teil1_0705.pdf http://www.my-cme.de/wms/cme_arzt/lernmodule/kollagenosen/beschreibung&course=108&wmsrubrik=kollagenosen http://www.eular.org/myUploadData/files/Programme%205th%20EULAR%20Capillaroscopy.pdf Cutolo M (2010) Atlas of capillaroscopy in rheumatic diseases. Elsevier, Milano Sander O, Iking-Konert C, Ostendorf B (2012) Taschenatlas Kapillarmikroskopie 2. Aufl. Actelion, Freiburg Sander O et al (2011) „DI-10“ Interobservervariabilität kapillarmikroskopischer Diagnostik im deutschsprachigen Raum. Z Rheumatol 70(Suppl 1):1–92 Smith V, Pizzorni C, De Keyser F et al (2010) Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study. Ann Rheum Dis 69:1092–1096 Gutierrez M, Bertolazzi C, Tardella M et al (2012) Interreader reliability in assessment of nailfold capillary abnormalities by beginners: pilot study of an intensive videocapillaroscopy training program. J Rheumatol 39(6):1248–1255 Matthias Reppel, Dissertation Düsseldorf 2012 (on file) Sebastiani M, Manfredi A, Colaci M et al (2009) Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 61(5):688–694 Sebastiani M, Manfredi A, Vukatana G et al (2012) Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 71(1):67–70 Wildt M, Wuttge DM, Hesselstrand R, Scheja A (2012) Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods. Clin Exp Rheumatol 30(2 Suppl 71):S50–S54 Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold video capillaroscopy – a new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32(5):841–848 Cutolo M, Sulli A, Pizzorni C, Smith V (2010) Capillaroscopy as an outcome measure for clinical trials on the peripheral vasculopathy in SSc-Is It useful? Int J Rheumatol pii:784947 Smith V, Decuman S, Sulli A et al (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 71(10):1636–1639 Murray AK, Vail A, Moore TL et al (2012) The influence of measurement location on reliability of quantitative nailfold videocapillaroscopy in patients with SSc. Rheumatology (Oxford) 51(7):1323–1330 Batticciotto A, Atzeni F, Foglia S et al (2012) Feet nailfold capillaroscopy is not useful to detect the typical scleroderma pattern. Clin Exp Rheumatol 30(2 Suppl 71):S116–S117 Sander O, Schroeder M, Ostendorf B et al (2010) „DI.05“ Kapillarmikroskopie: Eine Querschnittuntersuchung in der Bevölkerung. Z Rheumatol 69(Suppl 1):1–92 Hoerth C, KundiI M, Katzenschlager R, Hirschl M (2012) Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers. Vasa 41:19–26 Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736 Wollheim FA (2005) Classification of systemic sclerosis. Visions and reality. Rheumatology 44(10):1212–1216 Avouac J, Fransen J, Walker UA et al (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 70(3):476–481 Cutolo M, Sulli A, Secchi ME, Pizzorni C (2006) Capillaroscopy and rheumatic diseases: state of the art. Z Rheumatol 65(4):290–296 Koenig M, Joyal F, Fritzler MJ et al (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58(12):3902–3912 Ingegnoli F, Boracchi P, Gualtierotti R et al (2008) Prognostic model based on nailfold capillaroscopy for identifying Raynaud’s phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (Prognostic Index for Nailfold Capillaroscopic Examination). Arthritis Rheum 58(7):2174–2182 Ingegnoli F, Boracchi P, Gualtierotti R et al (2010) Improving outcome prediction of systemic sclerosis from isolated Raynaud’s phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology 49:797–805 Pavlov-Dolijanovic S, Damjanov NS, Stojanovic RM et al (2012) Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud’s phenomenon. Rheumatol Int 32(10):3039–3045 Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology 39(5):506–512 Merlen JF (1980) Phénomène de Raynaud et sclérodermie. Ann Cardiol Angéiol 29:333–337 Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 11(4):536–541 Sulli A, Secchi ME, Pizzorni C, Cutolo M (2008) Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients. Ann Rheum Dis 67:885–887 Rosato E, Gigante A, Barbano B et al (2011) In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage. Microvasc Res 82(3):410–415 Hofstee HM, Vonk Noordegraaf A, Voskuyl AE et al (2009) Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 68(2):191–195 Cutolo M (2012) Endothelin 1 receptor–antagonism (Bosentan) reduces the progression of microvascular damageas assessed by nailfold capillaroscopy inssc patients: a 2 year survey. Ann Rheum Dis 71(Suppl 3):684 Aschwanden M, Daikeler T, Jaeger KA et al (2008) Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis 67:1057–1059 Ingegnoli F, Zeni S, Meani L et al (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11(6):295–298 Riccieri V, Spadaro A, Ceccarelli F et al (2005) Nailfold capillaroscopy changes in systemic lupus erythematosus: correlations with disease activity and autoantibody profile. Lupus 14(7):521–525 Richter JG, Sander O, Schneider M, Klein-Weigel P (2010) Diagnostic algorithm for Raynaud’s phenomenon and vascular skin lesions in systemic lupus erythematosus. Lupus 19(9):1087–1095 Lambova SN, Müller-Ladner U (2012) Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: what we still have to learn? Rheumatol Int [Epub ahead of print] Cutolo M, Sulli A, Secchi ME et al (2006) Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology (Oxford) 45(Suppl 4):iv43–iv46 Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23(2):183–189 Nagy Z, Czirják L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud’s disease. J Eur Acad Dermatol Venereol 18(1):62–68 Redisch W, Messina EJ, Hughes G, McEwen C (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29(3):244–225 Richter J, Klein-Weigel P, Acar H et al (2012) Kapillarmikroskopische Befunde bei Lupus erythematodes – Einflüsse der klinischen Manifestationen und des Geschlechts. Z Rheumatologie (Suppl 2):21–22 Bhakuni DS, Vasdev V, Narayanan K et al (2011) Nail fold capillaroscopy: an innovative & practical approach using digital microscope. Ann Rheum Dis 70(Suppl 3):371 Pavlov-Dolijanovic S, Damjanov NS, Vujasinovic Stupar NZ et al (2012) Is there a difference in systemic lupus erythematosus with and without Raynaud’s phenomenon? Rheumatol Int [Epub ahead of print] Moneib HA, Salem SA, Aly DG et al (2012) Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations. J Dermatol 39(1):52–57 Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S (2009) Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Scand J Rheumatol 38(1):38–45 Ciołkiewicz M, Kuryliszyn-Moskal A, Klimiuk PA (2010) Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients. Clin Rheumatol 29(2):175–180 Pyrpasopoulou A, Triantafyllou A, Anyfanti P et al (2011) Capillaroscopy as a screening test for clinical antiphospholipid syndrome. Eur J Intern Med 22(6):e158–e159 Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60(4):407–409